Citation Impact
Citing Papers
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Heparin-Protein Interactions
2002 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Understanding adolescence as a period of social–affective engagement and goal flexibility
2012 Standout
Current oral treatments for erectile dysfunction
2002
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients
2009
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Nitric oxide/redox-based signalling as a therapeutic target for penile disorders
2006
Sexual activity after ileal pouch-anal anastomosis in Japanese patients with ulcerative colitis
2013
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7
2005
Polymer-supported reagents for multi-step organic synthesis: application to the synthesis of sildenafil
2000
Potential therapeutic targets for the treatment of detrusor overactivity
2004
Fluorescence Imaging in Surgery
2013 Nobel
Crystal Structures of Phosphodiesterases 4 and 5 in Complex with Inhibitor 3-Isobutyl-1-methylxanthine Suggest a Conformation Determinant of Inhibitor Selectivity
2004
Crystal Structures of Phosphodiesterases and Implications on Substrate Specificity and Inhibitor Selectivity
2007
Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
2006
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
The neural control of micturition
2008 Standout
Phosphodiesterase Type 5 Inhibitors: State of the Therapeutic Class
2007
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Immunohistochemical Distribution of cAMP- and cGMP-Phosphodiesterase (PDE) Isoenzymes in the Human Prostate
2006
WITHDRAWN: Hypericin-based Photodynamic Therapy Induces a Tumor-Specific Immune Response and an Effective DC-based cancer Immunotherapy
2014
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy
2014
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Oxytocin and social motivation
2011
Immunogenic cell death in cancer and infectious disease
2016 Standout
Erectile Dysfunction and Lower Urinary Tract
2008
Vinpocetine-induced stimulation of calcium-activated potassium currents in rat pituitary GH3 cells
2001
Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington′s disease transgenic mice prior to the onset of motor symptoms
2004
Erectile Dysfunction and the Internet: Drug Company Manipulation of Public and Professional Opinion
2013
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management
2011
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction
1999 Standout
Peptides in body fluids and tissues as markers of disease
2005
Clinical Chemistry of Companion Avian Species: A Review
2002 Standout
A new automated colorimetric method for measuring total oxidant status
2005 Standout
Fertility considerations in men with testicular cancer
2020
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
Dietary therapy for patients with hypocitraturic nephrolithiasis
2011
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Ureteroscopic laser treatment of upper urinary tract neoplasms
2010
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Fertility and infertility: Definition and epidemiology
2018 Standout
RhoA-mediated Ca2+ Sensitization in Erectile Function
2002
Effects of ??1-Adrenoceptor Antagonists on Male Sexual Function
2006
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network
2013
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma
2009
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
2012
Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk
2004
Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders
2010
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
The efficacy of a range of contact media as coupling agents in extracorporeal shockwave lithotripsy
2001
Peptide therapeutics: current status and future directions
2014 Standout
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
2008
The impact of ocular blood flow in glaucoma
2002 Standout
The effect of sildenafil citrate on bladder outlet obstruction: a mouse model
2008
Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days
2017
Epidemiology of stone disease across the world
2017 Standout
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction
2002
Androgens and Morphologic Remodeling at Penile and Cardiovascular Levels: A Common Piece in Complicated Puzzles?
2009
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension
2004
Sildenafil citrate does not affect cardiac contractility in human or dog heart
2003
Eraser Laser Enucleation of the Prostate: Technique and Results
2012
Multiple Conformations of Phosphodiesterase-5
2006
The Role of Nitric Oxide in Erectile Dysfunction: Implications for Medical Therapy
2006
Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour
2015
PDE5 inhibitors beyond erectile dysfunction
2007
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
2015
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Comparison of oxidative/antioxidative status of penile corpus cavernosum blood and peripheral venous blood
2004
Pelvic floor muscle function in continent and stress urinary incontinent women using dynamometric measurements
2004
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Sexual Function after Surgery for Prostate or Bladder Cancer
2006
New oral therapies for the treatment of erectile dysfunction
1998
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
2014 Standout
Comparative renal function in reptiles, birds, and mammals
1998
Systematic review and meta-analysis of enhanced recovery programmes in surgical patients
2014
Inhibition of the tonic contraction in the treatment of erectile dysfunction
2003
Safety and Efficacy of Eraser Laser Enucleation of the Prostate: Preliminary Report
2011
Quality of Information in YouTube Videos on Erectile Dysfunction
2020 Standout
Thermodynamic Analysis of the Heparin Interaction with a Basic Cyclic Peptide Using Isothermal Titration Calorimetry
1998
Pharmacology of Penile Erection
2001
Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation
2001
Amide bond formation and peptide coupling
2005 Standout
The impact of drugs on male fertility: a review
2017
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding
2004
Pharmacology of the Lower Urinary Tract
2001
Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries
2022 Standout
THE ORAL EFFICACY OF VARDENAFIL HYDROCHLORIDE FOR INDUCING PENILE ERECTION IN A CONSCIOUS RABBIT MODEL
2001
New photosensitizers for photodynamic therapy
2016 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Biomedical Importance of Indoles
2013 Standout
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
2003
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Sildenafil induces retinal vasodilatation in healthy subjects
2002
Absorption by water increases fluorescence image contrast of biological tissue in the shortwave infrared
2018 StandoutNobel
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Armin Becker being referenced
Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity—an experimental approach using the novel differential peptide display technology
2002
Semen Quality in Men with Malignant Diseases before and after Therapy and the Role of Cryopreservation
2007
Systemic and cavernous plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction
2001
A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro
1996
Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder
2000
Intracavernous CalcitoninGene-Related Peptide PlusProstaglandin E(1):Possible Alternative to PenileImplants in Selected Patients
1994
Laser Therapy for Upper Urinary Tract Transitional Cell Carcinoma: Indications and Management
2008
Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside
2001
Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis
2007
The 1,318-nm diode laser supported partial nephrectomy in laparoscopic and open surgery: preliminary results of a prospective feasibility study
2011
Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence
2001
Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction
1994
Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction
2001
Non‐genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue
2007
Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis
2000
Phosphodiesterase Isoenzymes in Human Ureteral Smooth Muscle: Identification, Characterization, and Functional Effects of Various Phosphodiesterase Inhibitors in vitro
1995
Cavernous and systemic testosterone plasma levels during different penile conditions in healthy males and patients with erectile dysfunction
2001
Systemic and cavernous plasma levels of endothelin 1 in healthy males during different functional conditions of the penis
2000
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue
2000
Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions
2003
Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction
2002
Tablette, Pumpe oder Spritze?
2008
Selective pharmacological manipulation of the smooth muscle tissue of the genitourinary tract: a glimpse into the future
1999
In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach
2006
Intraoperative Photodynamic Evaluation of Surgical Margins During Endoscopic Extraperitoneal Radical Prostatectomy with the Use of 5-Aminolevulinic Acid
2009
ELECTROMYOGRAPHICAL CHANGES OF THE LEVATOR ANI MUSCLE IN WOMEN WITH URINARY STRESS INCONTINENCE
2008
THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE-IV-INHIBITOR ROLIPRAM ON THE URETHERAL PERISTALSIS OF THE RABBIT IN VITRO AND IN VIVO
1998
525 A SIMPLE FAST TRACK REGIMEN FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
2012
THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVO
1998
Intracavernous application of SIN-I in rabbit and man: functional and toxicological results.
1993
ORAL PHENTOLAMINE AS TREATMENT FOR ERECTILE DYSFUNCTION
1998
The renal paracrine peptide system ? possible urologic implications of urodilatin
1996
ORAL PHENTOLAMINE AS TREATMENT FOR ERECTILE DYSFUNCTION
1998
PLASMA LEVELS OF CAVERNOUS AND SYSTEMIC NOREPINEPHRINE AND EPINEPHRINE IN MEN DURING DIFFERENT PHASES OF PENILE ERECTION
2000
THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE-IV-INHIBITOR ROLIPRAM ON THE URETHERAL PERISTALSIS OF THE RABBIT IN VITRO AND IN VIVO
1998
Is there an inhibitory role of cortisol in the mechanism of male sexual arousal and penile erection?
2003
Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle.
1998
PETROLEUM JELLY IS AN IDEAL CONTACT MEDIUM FOR PAIN REDUCTION AND SUCCESSFUL TREATMENT WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY
1999